Biotech & Pharma

Gorilla Adenovirus Brings Natural Edge to Cancer Therapy

30 sec read14 views0 listens

A gorilla-derived adenovirus platform offers a novel edge for cancer therapy due to its naturally embedded therapeutic properties. This vector exhibits low human seroprevalence, reduced liver sequestration, and selective replication in cancer cells, addressing key challenges in current virotherapy. Its substantial cargo capacity also surpasses that of adeno-associated viruses, making it suitable for delivering large transgenes and enabling oncolytic viruses to act as localized delivery systems for complex biologics, thereby enhancing antitumor immune responses.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model

Researchers at the University of Texas Medical Branch have developed a single-dose mRNA vaccine that provides full protection against the lethal Andes hantavirus in animal models. This breakthrough is critical for biotechnology professionals as it va...

Ali Nemati

Biotech & Pharma10 hours ago33 sec read

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

SonoThera has secured $125 million in Series B financing to advance its ultrasound-mediated genetic medicine platform toward clinical trials. This development is significant for the biotech sector because the proprietary RIPPLE and PORE technologies ...

Ali Nemati

Cybersecurity12 hours ago29 sec read

John the Ripper: Beginner's Tutorial and Review for 2026

John the Ripper remains a primary open-source tool for security professionals to audit credential strength and simulate password-cracking attacks in 2026. The software supports a wide range of hash types, including SSH keys and encrypted archives, al...

Ali Nemati

Gaming13 hours ago29 sec read

'The Only Way to Keep Bungie Alive Is to Support Marathon,' Ex-Destiny Community Manager Says

A former Bungie community manager stated that supporting the new Marathon game is crucial for the studio's survival, suggesting Bungie's issues predated Sony's acquisition and calling it an 'emergency acquisition.' This perspective challenges the nar...

Ali Nemati

Biotech & Pharma15 hours ago32 sec read

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more

The nonprofit Blood Cancer United has acquired the remaining supplies and investigational rights for the discontinued drug Luvelta to continue providing it to children with rare blood cancers. This unusual move highlights a critical shift in the phar...

Ali Nemati

Gorilla Adenovirus Brings Natural Edge to Cancer Therapy

Related Articles

Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

John the Ripper: Beginner's Tutorial and Review for 2026

'The Only Way to Keep Bungie Alive Is to Support Marathon,' Ex-Destiny Community Manager Says

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more